deltatrials
Completed OBSERVATIONAL NCT01569737

Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella (ellipseII)

Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Sponsor: HRA Pharma

Conditions Emergency Contraception
Interventions ella
Updated 13 times since 2017 Last updated: Sep 26, 2019 Started: Nov 18, 2014 Primary completion: Jun 29, 2018 Completion: Jun 29, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01569737, this observational or N/A phase trial focuses on Emergency Contraception and remains completed. Sponsored by HRA Pharma, it has been updated 13 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Apr 2018 · 10 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2019 · 15 months · monthly snapshot~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2022 — Jan 2023 [monthly]

    Completed

  5. Dec 2021 — Dec 2022 [monthly]

    Completed

▶ Show 8 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2019 — Jan 2021 [monthly]

    Completed

  3. Aug 2018 — Nov 2019 [monthly]

    Completed

    Status: Recruiting → Completed

  4. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  5. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  6. Jun 2017 — Apr 2018 [monthly]

    Recruiting NA

    Status: Unknown Status → Recruiting

  7. Feb 2017 — Jun 2017 [monthly]

    Unknown Status NA

  8. Jan 2017 — Feb 2017 [monthly]

    Unknown Status NA

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • HRA Pharma
Data source: HRA Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations